Physician

Nephrology

Sergio R. Acchiardo practices Nephrology. Dr. Sergio R. Acchiardo is also a published doctor. He has 78 paper published. The most recent paper is: Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.

Publications

---

• INSIGHT potentially prevents and treats depressive and anxiety symptoms in black women caring for chronic hemodialysis recipients.
• Heart rate variability and mortality in patients with end stage renal disease.
• Hypertension of renal origin.
• Fluoride kinetics after enflurane anesthesia in healthy and anephric patients and in patients with poor renal function.
• Beta 2-microglobulin levels in patients with renal insufficiency.
• [Experience with peritoneal dialysis in the treatment of chronic and acute renal insufficiency].
• [Extracorporeal dialysis in acute renal failure].
• 131-I hippuran in the evaluation of transplanted kidneys.
• Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential Hypertension.
• Aminocaproic acid in prolonged hematuria of patients with sicklemia.
• Malignant Hypertension in blacks. Malignant intrarenal arterial disease as observed by light and electron microscopy.
• Aberrant creatine kinase and lactate dehydrogenase response in a myocardial infarct patient.
• [ PERITONEAL DIALYSIS].
• [THE REACTIONS OF WAALER-ROSE AND OF LATEX IN RHEUMATOID ARTHRITIS].
• [EVOLUTION OF CHRONIC NEPHROPATHS WITH SEVERE OR MALIGNANT Hypertension UNDER TREATMENT WITH GUANETHIDINE SULPHATE].
• [HORMONAL TREATMENT OF ENDEMIC GOITER].
• [Effects of hypotensive treatment with parenteral reserpine in the hypertensive emergencies of nephropathies with renal insufficiency].
• [Zollinger-Ellison syndrome].
• [Experience with demethylchlortetracycline in the treatment of urinary infections].
• [Rheumatoid arthritis and amyloidosis].
• Effect of essential amino acids (EAA) on chronic hemodialysis (CHD) patients (PTS).
• Multiple hepatitis B virus markers in dialysis patients.
• Hypersensitivity reaction on first-time exposure to cuprophan hollow fiber dialyzer.
• Beta 2-microglobulin, amyloidosis, and dialysis.
• An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation.
• End-stage renal disease and its treatment in Latin America in the twenty-first century.
• Malnutrition as the main factor in morbidity and mortality of hemodialysis patients.
• Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.
• Procainamide-induced myasthenia-like weakness in a patient with peripheral neuropathy.
• Radiographic manifestations of aluminum-induced bone disease.
• Folic acid dosage for chronic hemodialysis patients.
• Treatment of patients with severe Hypertension by inhibition of angiotensin-converting enzyme.
• Nonpercutaneous transmission of hepatitis B to the families of hemodialysis patients.
• Experience with hemodialysis and renal transplantation in patients with malignant Hypertension.
• The comparative bioavailability of liquid, wax-matrix, and microencapsulated preparations of potassium chloride.
• Dialyzability and pharmacokinetics of indomethacin in adult patients with end-stage renal disease.
• Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients.
• Does low protein diet halt the progression of renal insufficiency?
• Therapeutic assessment of Slow-K and K-tab potassium chloride formulations in hypertensive patients treated with thiazide diuretics.
• Morbidity and mortality in hemodialysis patients.
• Evaluation of hemodialysis patients treated with erythropoietin.
• The efficacy of nutrition support in infected patients with chronic renal failure.
• Is hematologic response to iron and erythropoietin in hemodialysis patients affected by other factors?
• Is Na+ modeling necessary in high flux dialysis?
• Evaluation of CAPD prescription.
• Inadequate dialysis increases gross mortality rate.
• Urea kinetics evaluation of hemodialysis and CAPD patients.
• Arteriovenous fistulas for hemodialysis: experience with 100 cases.
• Ultrastructural changes in gentamicin nephrotoxicity.
• Acetohexamide hypoglycemia: treatment by peritoneal dialysis.
• Peritoneal dialysis in the treatment of acetohexamide-induced hypoglycemia.
• Role-effectiveness of the pharmacist in the treatment of hemodialysis patients.
• Fluoxymesterone therapy in anemia of patients on maintenance hemodialysis: comparison between patients with kidneys and anephric patients.
• Simplified ultrafiltration preceding dialysis.
• Malignant Hypertension due to musculo-mucoid intimal hyperplasia of intrarenal arteries. Absence of renal fibrinoid necrosis.
• Management of muscle cramps in hemodialysis patients. Controlled prospective study.
• An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells.
• Implications for the role of endogenous nitric oxide inhibitors in hemodialysis hypotension.
• A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
• Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a ...
• Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
• Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
• Normal circulating adult human red blood cells contain inactive NOS proteins.
• Biphasic changes in nitric oxide generation in hemodialyzed patients with end-stage renal disease treated with recombinant human erythropoietin.
• Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.
• Hypotension during hemodialysis: role for nitric oxide.
• Nutrition in the critical care settings of renal diseases.
• Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole.
• Uremia and adequate dialysis treatment.
• Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients.
• Porphyria cutanea tarda in a chronic hemodialysis patient.
• The pharmacokinetics of trichlormethiazide in hypertensive patients with normal and compromised renal function.
• General overview: urea kinetic modeling.
• Are high flux dialysis and erythropoietin treatment in a collision course?
• Liquid and solid potassium chloride: bioavailability and safety.
• Dialysis catheter-induced superior vena cava syndrome and downhill esophageal varices.
• Iron requirements in hemodialysis.

Conditions Treated

---

• Hypertension

Doctors Specialties

---

• Nephrology

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• Great West Healthcare-Cigna PPO

Education

---

• Cleveland Clinic Foundation
• University of Chile

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Adnan Naseer, MD This Doctor is OpenDoctor Recommended.
	Dr. Omer M. Asif Siddiqui, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert S. Boger, MD This Doctor is OpenDoctor Recommended.
	Dr. Aneel Kumar, MD This Doctor is OpenDoctor Recommended.
	Dr. Bobby J. Kelley, MD This Doctor is OpenDoctor Recommended.
	Dr. Arafat Y. Melhem, MD This Doctor is OpenDoctor Recommended.
	Dr. Melissa J. Yeh, MD
	Dr. Deepika R. Pulusani, MD This Doctor is OpenDoctor Recommended.
	Dr. Sanjeev K. Mittal, MD This Doctor is OpenDoctor Recommended.
	Dr. Nawar E. Mansour, MD This Doctor is OpenDoctor Recommended.
	Dr. Tameez U. Din, MD This Doctor is OpenDoctor Recommended.
	Dr. Lekha K. George, MD This Doctor is OpenDoctor Recommended.
	Dr. Audrey W. Coo, MD This Doctor is OpenDoctor Recommended.
	Dr. Julio P. Ruiz, MD This Doctor is OpenDoctor Recommended.
	Dr. Yashwant Chowdhary, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog